Skip to main content
Annals of Translational Medicine logoLink to Annals of Translational Medicine
. 2024 Jul 5;12(5):105. doi: 10.21037/atm-2024-6

Erratum to lncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins

Editorial Office1
PMCID: PMC11534751  PMID: 39507439

This article (1) titled “LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins” (doi: 10.21037/atm-21-4995), unfortunately contains an error in the Funding section. The Funding ‘Guangzhou Science and Technology Plan Project (Grant No. 202102021238 to FN)’ should be added to the Funding section. The updated Funding section is presented below.

The authors apologize for the oversight.

Click here to view the updated version of the article.

Supplementary

The article’s supplementary files as

DOI: 10.21037/atm-2024-6

Acknowledgments

Funding: This work was supported in part by National Natural Science Foundation of China (NSFC) (Grant No. 81702270 to FN, 81802335 to YS), Affiliated Hospital of Guangzhou Medical University Foundation (Grant No. 2013A41 to JD), Clinical Key Specialty Construction Project of Guangzhou Medical University (Grant No. YYPT202017), and Guangzhou Science and Technology Plan Project (Grant No. 202102021238 to FN).

References

  • 1.Song Y, Du J, Lu P, et al. LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins. Ann Transl Med 2021;9:1621. 10.21037/atm-21-4995 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

The article’s supplementary files as

DOI: 10.21037/atm-2024-6

Articles from Annals of Translational Medicine are provided here courtesy of AME Publications

RESOURCES